From Healthcare & Pharma and USA - 9 Aug 2017 08:01 UTC Acorda comes under pressure to sell itself Add to My Stories Print page Add to Favourites The beleaguered New York-based biotechnology company Acorda Therapeutics is coming under pressure to put itself up for sale by an activist investor which has recently increased its stake in the…